ADVFN - Advanced Financial Network.
HOME» NYSE » O » OCR Stock Price » OCR Stock News

Omnicare Share News

 Omnicare Inc. Stock Price
OCR Stock Price
 Omnicare Inc. Stock Chart
OCR Stock Chart
 Omnicare Inc. Stock News
OCR Stock News
 Omnicare Inc. Company Information
OCR Company Information
 Omnicare Inc. Stock Trades
OCR Stock Trades

Omnicare Swings To 4Q Loss On Charges; Issues Weak Fiscal-Year Outlook

DOW JONES NEWSWIRES Omnicare Inc. (OCR) swung to a fourth-quarter loss on a litigation settlement charge and other expenses, although results excluding those items met Wall Street's expectations. The company projected full-year earnings from continuing operations of $2.05 to $2.15 a share on revenue of $6 billion to $6.1 billion. Analysts polled by Thomson Reuters expected $2.2 a share and $6.28 billion in revenue. The provider of drugs to nursing homes and assisted-living centers struggled with falling earnings in the second and third quarters and the unsealing of a lawsuit alleging the company defrauded government health programs by submitting false claims. The company said those allegations were "without merit." In August, Moody's Investors Service cut its outlook on Omnicare to negative in the wake of the sudden departure of the company's then-chief executive, Joel Gemunder, earlier that month. The company in December named McKesson Corp. (MCK) pharmaceutical unit president John Figueroa to the post. Omnicare reported a fourth-quarter loss of $65.3 million, or 57 cents a share, compared with a year-earlier profit of $79.8 million, or 68 cents a share. Excluding litigation settlement charges and other effects, adjusted earnings from continuing operations fell to 51 cents a share from 74 cents. Revenue rose 1.2% to $1.56 billion. Analysts expected per-share earnings of 51 cents a share on revenue of $1.56 billion. Gross margin narrowed to 22% from 23.9%. Omnicare shares closed at $25.91 Wednesday and weren't active premarket. -By Drew FitzGerald and John Kell, Dow Jones Newswires; 212-416-2909; Andrew.FitzGerald@dowjones.com;

Stock News for Omnicare (OCR)
DateTimeHeadline
08/25/201517:08:24Post-effective Amendment to an Automatic Shelf Registration of...
08/25/201517:01:32Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201517:01:07Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201517:00:40Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201517:00:14Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:59:47Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:59:47Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:59:22Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:59:22Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:58:53Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:58:53Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:58:00Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:57:36Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:57:35Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/25/201516:57:08Post-effective Amendment to an S-8 Filing (s-8 Pos)
08/20/201517:35:24Statement of Changes in Beneficial Ownership (4)
08/20/201517:34:24Statement of Changes in Beneficial Ownership (4)
08/20/201517:32:41Statement of Changes in Beneficial Ownership (4)
08/20/201517:31:49Statement of Changes in Beneficial Ownership (4)
08/20/201517:29:33Statement of Changes in Beneficial Ownership (4)

Omnicare and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad